STUDY OF REDUCTION OF COMPLICATION RISK IN ARTERIAL HYPERTENSION USING COMBINATION THERAPY
Keywords:
arterial hypertension, combination therapy, cardiovascular complications, antihypertensive therapy, target organ damageAbstract
Arterial hypertension is one of the most significant global health problems and a leading risk factor for cardiovascular diseases. Modern international guidelines recommend combination therapy as first-line treatment for most patients with arterial hypertension. The aim of this study was to evaluate the effectiveness of combination therapy in reducing complications in patients with arterial hypertension. The results showed that combination therapy significantly improves blood pressure control, reduces cardiovascular complications, and prevents target organ damage.
References
1. Jamoldinovich, A. I. THE RELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK IN CHRONIC HEART FAILURE.
2. Williams B., Mancia G., Spiering W., et al. (2018). ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal.
3. Mancia G., Kreutz R., Brunström M., et al. (2023). ESH Guidelines for hypertension management.
4. Jamerson K., Weber M.A., Bakris G.L., et al. (2008). ACCOMPLISH Trial. New England Journal of Medicine.
5. Dahlöf B., Sever P.S., Poulter N.R., et al. (2005). ASCOT-BPLA Study. Lancet.
6. SPRINT Research Group (2015). Intensive blood pressure control. New England Journal of Medicine.
7. World Health Organization (2021). Hypertension Fact Sheet.
